Collectively, these findings suggest that C1-GBM is more consistent with a mesenchymal-like molecular profile characterized by PTEN/NF1 alterations, while C2-GBM is more consistent with a proneural/classical-like profile with frequent TP53 mutations. The gene discussed is TP53; the disease is glioblastoma.